News

Fierce Pharma4d
Regeneron's Eylea franchise suffers double whammy with sales decline and surprise FDA rejection
After consecutive setbacks at the FDA, Regeneron's string of recent troubles with its Eylea franchise is continuing to pull ...
PMLive11d
FDA approves pre-filled syringe version of argenx’s immune disorder drug Vyvgart
The US Food and Drug Administration (FDA) has approved a pre-filled syringe version of argenx’s Vyvgart, giving generalised ...
BioSpace4d
Regeneron Shares Tumble as Eylea Declines Make for a ‘Messy Quarter’ To Come
The company’s $3 billion in earnings for the first quarter missed on both top and bottom line, according to BMO Capital ...